The largest database of trusted experimental protocols

18 protocols using pd98059

1

Insulin Glargine Cytokine Secretion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MIMIC® PTE cultures were incubated with the following agents immediately following PBMC application: 10 μg/ml anti-IGF-IR/IGF-1R antibody (1H7) (Thermo Fisher Scientific, Waltham, MA, USA),10 nM insulin receptor AB antagonistic peptide S961 [15 (link)],10 nM rapamycin (mTOR inhibitor, InvivoGen) or 25 nM PD98059 (MEK1 and MEK2 Inhibitor, InvivoGen). (All blocking reagents were adapted from published protocols [16 (link)–18 (link)]). One hour later, 5 U/ml Glaritus, Basalog, or originator insulin glargine were added to the wells and incubated for 48 hours at 37°C and 5% CO2. Thereafter, the culture supernatants were harvested and analyzed for secreted cytokines by multiplex assay.
In some experiments, insulin glargine was removed from the formulation prior to this analysis. Briefly, insulin glargine (175 μg/mL) was incubated with 5 μg/ml anti-insulin mAb (Cell Signaling Technology, Danvers, MA, USA) for 24 hours at 4°C. The reaction mix was then passed through an Amicon Ultra 30 kDa cut-off filter (Millipore, Billerica, MA, USA) to retain the insulin glargine. The filtrate was examined by SDS-PAGE to confirm the insulin glargine was removed from the product.
+ Open protocol
+ Expand
2

miR-340 Inhibition and Overexpression Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
miRZip scrambled hairpin RNA control and miRZip 340 microRNA inhibitor constructs (System Biosciences Inc., Mountain View, CA) were used to inhibit hsa-miR-340 and PCMV-MIR340 and PCMV-MIR control microRNA over expression vectors (Origene, Rockville, MD) were used to over express hsa-miR-340. Plasmid DNA was transfected with Lipofectamine 2000 (Life Technologies), 24 hours later the transfection mixture was replaced with fresh media and after 48 hours post-transfection, cells were collected for RNA, protein or cell-based assays and analysis. For the phosphorylated Erk1/2 experiments, 48 hours post-transfection, the MEK1 inhibitor PD98059 (Invivogen, San Diego, CA) in DMSO was applied to cells at a 50mM final concentration to cells for a 3 hour period, after which cells were collected for downstream applications.
+ Open protocol
+ Expand
3

Comprehensive Antibody Panel for Cellular Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies specific for IgG (No. 2729), GAPDH (No. 5174), XAF1 (No. 13805), IRF1 (No. 8478 and 79132), RIG-I (No. 3743), p-TBK1 (No. 5483), TBK1 (No. 3504), p-IRF3 (No. 29047), IRF3 (No. 4302), p-STAT1 (No. 9167), STAT1 (No. 14994), p-ERK1/2 (No. 9101), ERK1/2 (No. 4695), p-JNK (No. 4668), JNK (No. 9252S), p-p38 (No. 9215), p38 (No. 9212), p-p65 (No. 3033), p65 (No. 6956), HA-Tag (6E2)-HRP (No. 2999), Myc-Tag-HRP (No. 2040), and K48-Ub-HRP (No. 12805) were purchased from Cell Signaling Technology (Danvers, MA, USA). HRP-linked secondary antibodies specific for rabbit IgG and mouse IgG were also from Cell Signaling Technology. Primary antibodies against α-Tubulin (No. T5168), the anti-FLAG M2 Affinity Gel (No. A2220), and anti-HA-Agarose (No. A2095) were from Sigma (St.Louis, MO, USA). NF-κB inhibitor BAY11-7082, MAPK pathways inhibitors, including SB203580, PD98059 and SP600125, and JAK Inhibitor INCB018424 were purchased from InvivoGen (San Diego, CA).
+ Open protocol
+ Expand
4

Detection of Antiviral Signaling Molecules

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti‐α‐tubulin antibody (#T5168) were purchased from Sigma‐Aldrich (St. Louis, MO). PolyI:C, biotin‐PolyI:C, polydA:dT, NF‐κB inhibitor BAY11‐7082, and MAPK inhibitors including SB203580, PD98059, and SP600125 were from InvivoGen (San Diego, CA). Recombinant mouse IFN‐α and IFN‐β were from PBL Assay Science (Piscataway, NJ). Recombinant human IFN‐β was from R&D system (Minneapolis, MN). Primary antibodies against GAPDH (#5174), β‐Actin (#3700), pSTAT1 (Tyr701, #9167), STAT1 (#14994), pTBK1 (Ser172, #5483), TBK1 (#3504), pIRF3 (Ser396, #29047), IRF3 (#4302), peIF2α (Ser51, #3398), eIF2α (#5324), Flag (#14793), and HRP‐linked secondary antibodies anti‐rabbit IgG (#7074) and anti‐mouse IgG (#7076) were from Cell Signaling Technology (Danvers, MA). Anti‐PKR (18244‐1‐AP) was purchased from Proteintech (Wuhan, China), anti‐IFIT2 (sc‐398610) was from Santa Cruz (Santa Cruz, CA). The fluorescence secondary antibodies were purchased from LI‐COR (Lincoln, NE).
+ Open protocol
+ Expand
5

Modulation of Inflammatory Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human interferon β (IFNβ), tumor necrosis factor α (TNFα), and interleukin-1 β (IL-1β) were purchased from Peprotech, resuspended in phosphate buffered saline (PBS) and used at 10 ng/mL unless otherwise specified. AL8810 (PGF inhibitor) was purchased from Santa Cruz Biotechnologies. SP600125 (JNK inhibitor), PD98059 (MEK1/2 inhibitor), and Ruxolitinib (JAK/STAT inhibitor) were purchased from Invivogen. AL8810, SP600125, and PD98095 were reconstituted per the manufacturer’s instructions, used at the indicated concentrations, and were added to cells at the same time as viral inoculation. Ruxolitinib was also reconstituted per the manufacturer’s instructions and used at the specified concentrations, but cells were instead pre-treated for 2h prior to infection. Ionomycin was purchased from Sigma, reconstituted in PBS, and used at the specified concentrations and time points. Mock and untreated controls were “stimulated” with the appropriate vehicle only at the highest volume used for the given experiment and reagent concentration.
+ Open protocol
+ Expand
6

Inhibiting ERK1/2 and NF-kB Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ERK1/2 pathway specific inhibitor PD98059 (Peprotech, Rocky Hill, NJ) and the NF-kB pathway specific inhibitor Celastrol (Invivogen, San Diego, CA) were stored at -20° C. Prior to EHEC infection, the NCM460 cells were incubated with either PD98059 (50 μM) or Celastrol (100 nM) for 1h. The inhibitors were kept during the 5 h of infection.
+ Open protocol
+ Expand
7

Preparation of Compound Stock Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise stated, all chemicals were purchased from Sigma (St Louis, MO, USA). Stock solutions of amitriptyline (100 mM), bupropion (100 mM), citalopram (10 mM), EGTA (50 mM), fluoxetine (10 mM), and N-acety-l-cysteine (NAC, 300 mM) were prepared in distilled water (DW). 5-fluorouracil (100 μg/mL), doxorubicin (2 mg/mL), paroxetine (20 mM), PD98059 (20 mM), SB203580 (20 mM), SP600125 (20 mM), taxol (1 mg/mL), tianeptine (100 mM), and Z-VAD-FMK (10 mg/mL, InvivoGen, San Diego, CA, USA) were dissolved in dimethyl sulfoxide (DMSO). The solutions were then diluted in culture medium to the working concentration. Where DMSO was used as a solvent, solution containing equivalent concentration of DMSO was used as a control. Final DMSO concentrations for chemicals indicated above were ~0.1% (v/v).
Dulbecco’s modified Eagle’s medium (DMEM/F12), DMEM, fetal bovine serum (FBS), and horse serum were purchased from Gibco-BRL (Gaithersburg, MD, USA). RPMI-1640 was purchased from Lonza (Walkersville, MD, USA). Total glutathione assay kit was purchased from Assay Designs (Ann Arbor, MI, USA). FLICA apoptosis detection kit was purchased from Immunochemistry Technologies (Bloomington, MN, USA). MitoSox was purchased from Invitrogen (Carlsbad, CA, USA). JC-1 mitochondrial membrane potential detection kit was purchased from Biotium Inc (Hayward, CA, USA).
+ Open protocol
+ Expand
8

Evaluating Pathway Inhibitors in LPS-Induced Airway Disorders

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess the effects of ERK, JNK, and p38 pathway on the airway disorders induced by LPS in our model, where indicated, mice were treated with the specific inhibitors of ERK (PD98059, invivogen, 10 mg/kg) or JNK (SP600125, invivogen, 20 mg/kg) or p38 (SB203580, invivogen, 5 mg/kg) respectively. The inhibitor was solubilized in 2% dimethyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO, USA). Treatments with inhibitors or DMSO alone were given intraperitoneally 1 h before and 2 h after the first LPS inoculation on day 35, and once a day successively from day 36 to day 41.
+ Open protocol
+ Expand
9

Investigating Chemerin and Growth Factor Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 or MCF-7 cells (2.5 × 103 cells/well) were incubated in a chamber slide with complete medium for 24 h. The cells were treated with chemerin (80 nM) or SB525334 (TGF-β type I receptor inhibitor, 20 μM: Selleckchem, Houston, USA) in the presence of TGF-β (10 ng/mL) for 24 h. In addition, the cells were treated with chemerin (80 nM), ZSTK474 (PI3K inhibitor, 20 μM: Selleckchem), or PD98059 (MEK1/2 inhibitor, 20 μM: InvivoGen, San Diego, USA) in the presence of IGF-1 (40 ng/mL) for 24 h. The cells were fixed with 4% paraformaldehyde and permeabilized with Triton X-100 buffer. After blocking with 2% goat serum in PBS, the cells were incubated with specific primary antibodies against β-catenin, E-cadherin, or SMAD2/3 overnight at 4 °C. After washing, the cells were incubated with Alexa Fluor 488 goat anti-mouse IgG and Alexa Fluor 594 goat anti-rabbit IgG (Invitrogen) for 1 h at room temperature. The slide was mounted using Vectashield mounting medium with DAPI (Vector Laboratories, CA, USA). The images were collected using a Zeiss LSM 700 confocal microscope.
+ Open protocol
+ Expand
10

Isolation and Culture of Murine Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells and naïve CD4+ T cells were isolated from mouse spleen using mouse B cell and naïve T cell isolation kits (Miltenyi Biotech) according to previously published optimized protocols 30 , 31 . NIH3T3 mouse fibroblast cell line (ATCC CRL-1658) was provided by O. Voss. Phoenix Eco retroviral packaging cell line (ATCC CRL-3214) was purchased from American Type Culture Collection (ATCC). All cells were maintained in RPMI 1640 media supplemented with 50 μM 2-mercaptoethanol, 50 U/ml penicillin, 50 μM streptomycin, 2 mM L-glutamine, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate and 10 mM HEPES unless otherwise specified. The pathway inhibitors SP600125, PD98059, Wortmannin, Rapamycin, SB202190 were purchased from Invivogen. MHY1485 and Akt Inhibitor IV (Akt IV) were purchased from Sigma-Aldrich.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!